BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 10802273)

  • 1. Performance of the frameless GyneFix and the TCu380A IUDs in a 3-year multicenter, randomized, comparative trial in parous women.
    Wu S; Hu J; Wildemeersch D
    Contraception; 2000 Feb; 61(2):91-8. PubMed ID: 10802273
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Randomized comparative trial in parous women of the frameless GyneFix and the TCu380A intrauterine devices: long-term experience in a Chinese family planning clinic.
    Cao X; Zhang W; Gao G; Van Kets H; Wildemeersch D
    Eur J Contracept Reprod Health Care; 2000 Jun; 5(2):135-40. PubMed ID: 10943576
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Performance of the frameless IUD (Flexigard prototype inserter) and the TCu380A after six years as part of a WHO multicenter randomized comparative clinical trial in parous women.
    Hui-Qin L; Zhuan-Chong F; Yu-Bao W; Yiao-Lin H; Van Kets H; Wildemeersch D
    Adv Contracept; 1999; 15(3):201-9. PubMed ID: 11019951
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The frameless copper IUD (GyneFix) and the TCu380A IUD: results of an 8-year multicenter randomized comparative trial.
    Meirik O; Rowe PJ; Peregoudov A; Piaggio G; Petzold M;
    Contraception; 2009 Aug; 80(2):133-41. PubMed ID: 19631788
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Comparative study of intrauterine devices: TCu380A and Flexigard].
    Andrade AT; Araujo DA; Abranches AA
    Bol Cent Biol Reprod; 1993; 12(1):16-9. PubMed ID: 12345520
    [TBL] [Abstract][Full Text] [Related]  

  • 6. One-year clinical experience with FlexiGard.
    Batar I
    Contraception; 1992 Oct; 46(4):307-12. PubMed ID: 1486769
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of frameless intrauterine devices and systems in young nulliparous and adolescent women: results of a multicenter study.
    Wildemeersch D; Jandi S; Pett A; Nolte K; Hasskamp T; Vrijens M
    Int J Womens Health; 2014; 6():727-34. PubMed ID: 25125987
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immediate postplacental insertion of GYNE-T 380 and GYNE-T 380 postpartum intrauterine contraceptive devices: randomized study.
    Tatum HJ; Beltran RS; Ramos R; Van Kets H; Sivin I; Schmidt FH
    Am J Obstet Gynecol; 1996 Nov; 175(5):1231-5. PubMed ID: 8942493
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Current status of frameless anchored IUD for immediate intracesarean insertion.
    Wildemeersch D; Goldstuck ND; Hasskamp T
    Dev Period Med; 2016; 20(1):7-15. PubMed ID: 27416620
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immediate post-abortal insertion of the frameless GyneFix IUD: initial experience in China.
    Cao X; Zhang W; Gao Y; Zhao X; Lin N; Wang L; Li C; Song L; Zhang W; Zhang Z; van Kets H; Wildemeersch D
    Br J Fam Plann; 2000 Apr; 26(2):85-8. PubMed ID: 10773600
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effectiveness, safety, and acceptability of postplacental insertion of GyneFix postpartum intrauterine device among women undergoing cesarean section: A multicenter prospective cohort study in China.
    Che Y; Hou GF; Zhang HP; Yang H; Lin SJ; Gan T; Yang WH; Shi CH; Ren WJ; Xu YQ; Yin BM; Chen TT; Gan YJ; Zhang Y; Zhang Y; Cheng LN
    Contraception; 2023 Jun; 122():109999. PubMed ID: 36849032
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Frameless versus classical intrauterine device for contraception.
    O'Brien PA; Marfleet C
    Cochrane Database Syst Rev; 2001; (4):CD003282. PubMed ID: 11687184
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Precision intrauterine contraception may significantly increase continuation of use: a review of long-term clinical experience with frameless copper-releasing intrauterine contraception devices.
    Wildemeersch D; Pett A; Jandi S; Hasskamp T; Rowe P; Vrijens M
    Int J Womens Health; 2013; 5():215-25. PubMed ID: 23658502
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of expulsions following intracesarean placement of an innovative frameless copper-releasing IUD (Gyn-CSĀ®) versus the TCu380A: A randomized trial.
    Unal C; Eser A; Tozkir E; Wildemeersch D
    Contraception; 2018 Apr; ():. PubMed ID: 29678365
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term reversible contraception. Twelve years of experience with the TCu380A and TCu220C.
    Contraception; 1997 Dec; 56(6):341-52. PubMed ID: 9494767
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The TCu 380A IUD and the frameless IUD "the FlexiGard": interim three-year data from an international multicenter trial. UNDP, UNFPA, and WHO Special Programme of Research, Development and Research Training in Human Reproduction, World Bank: IUD Research Group.
    Contraception; 1995 Aug; 52(2):77-83. PubMed ID: 8536451
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical performance of the TCu 380A and Lippes Loop IUDs in three developing countries.
    Farr G; Amatya R; Acosta M; Ekwempu C; Kisninci H
    Contraception; 1995 Jul; 52(1):17-22. PubMed ID: 8521710
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The frameless GyneFix intrauterine implant: a major improvement in efficacy, expulsion and tolerance.
    van Kets H; Vrijens M; Van Trappen Y; Delbarge W; van der Pas H; Temmerman M; Depypere H; Batar I; Barri P; Martinez F
    Adv Contracept; 1995 Jun; 11(2):131-42. PubMed ID: 7491854
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A comparative study of two techniques used in immediate postplacental insertion (IPPI) of the Copper T-380A IUD in Shanghai, People's Republic of China.
    Xu JX; Rivera R; Dunson TR; Zhuang LQ; Yang XL; Ma GT; Chi IC
    Contraception; 1996 Jul; 54(1):33-8. PubMed ID: 8804806
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The FlexiGard 330 ICC, an ultrasound evaluation.
    Wildemeersch D; Defoort P; Martens G
    Contraception; 1992 Nov; 46(5):471-6. PubMed ID: 1458893
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.